3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Breast Neoplasms
48
Arthralgia
3
Advanced Breast Cancer
3
Polycystic Ovary Syndrome
2
Osteoporosis
2
Fractures, Bone
2
Carcinoma, Intraductal, Noninfiltrating
2
Breast Diseases
2
Breast Cancer Female
2
Sexuality
1
Sexual Dysfunctions, Psychological
1
Neurotoxicity Syndromes
1
Neoplasm Metastasis
1
Luminal B/HER2-negative Breast Cancer
1
Leiomyoma
1
Infertility
1
Hormone-receptor-positive Breast Cancer
1
Hormone Receptor Positive Breast Carcinoma
1
Hormonal Receptors Positive, HER2 Negative, Advanced Breast Cancer
1
HR+/HER2- Early Breast Cancer
1
HR+/HER2+ Early Breast Cancer
1
Fatigue
1
Estrogen Receptor and/or Progesterone Receptor Positive
1
Endometrial Stromal Tumors
1
Endometrial Neoplasms
1
Bulbo-Spinal Atrophy, X-Linked
1
Breast Carcinoma In Situ
1
Breast Cancer Metastatic
1
Bone Diseases, Metabolic
1
Anatomic Stage I Breast Cancer AJCC v8
1
Interventions
exemestane
1
Vorinostat
1
Surgical Procedures, Operative
1
Mifepristone
1
Letrozole
1
Aromatase Inhibitors
1
Anastrozole
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Endometrial Stromal Tumors
×
Aromatase Inhibitors
×
Clear all
NCT03624244
2026-02-17
BFR-ESS
Centre Leon Berard
Phase 2
Recruiting
40 enrolled